ALPL and hypophosphatasia: Furthermore, Zhang et al. suggested that systemic LiCl injections can be a promising therapy for patients with HPP, as LiCl can improve dentin mineralization, dentin mineral density, and the height and bone mass of alveolar bone in mouse models with ALPL depletion.